VC firm
Advent Life Sciences
Also known as Advent Harrington Impact, Advent Life Sciences Fund III LP, Advent Life Sciences Growth, Advent Life Sciences Growth Fund LP, Advent Life Sciences LLP, Advent-Harrington Impact Fund LP
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- London, United Kingdom
- Assets under management
- $830MForm ADV private fund GAV, as of 2026-03-26Source (opens in a new tab)
- Funds
- 8
- Legal name
- Advent Life Sciences LLP
- adventls.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Team page (opens in a new tab)
Record updated 29 September 2026
About
Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA.
Investment approach
- Thesis
- We take a hands-on approach and work in close alignment and partnership with our management teams to realise their vision with the goal of achieving superior financial returns by bringing innovation to patients.Source (opens in a new tab)
- Investing status notes
- We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach.
Funds
- Advent Life Sciences Growth Fund LP
- $9.8MVintage 2024, SPV, SEC amount sold
- Advent-Harrington Impact Fund LP
- $41.6MVintage 2020, Main fund, SEC amount sold
- Advent Life Sciences Fund III LP
- $24.8MVintage 2018, SPV, SEC amount sold
- ADVENT LIFE SCIENCES FUND I LP
- Main fund
- ADVENT LIFE SCIENCES II CO-INVEST LP
- SPV
- ADVENT LIFE SCIENCES GROWTH FUND LP
- Main fund
- BIOMOTIV LLC
- Main fund
- ADVENT LIFE SCIENCES FUND II LP
- Main fund
SEC registration
- Registered adviser
- ADVENT LIFE SCIENCES LLP
- CRD number
- 173031 (opens in a new tab)
- SEC file number
- 802-92178
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $830Mas of 2026-03-26
- Private funds reported
- 7
- Principal office
- LONDON, United Kingdom
- SEC CIK
- 1761089, 1827544, 2040586
Locations
- Headquarters
- London, United Kingdom